Browse
Submit Data
Databases
API
Help

Dataset Information

5 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CCN5: biology and pathophysiology.

ABSTRACT: CCN5 is one of six proteins in the CCN family. This family of proteins has been shown to play important roles in many processes, including proliferation, migration, adhesion, extracellular matrix regulation, angiogenesis, tumorigenesis, fibrosis, and implantation. In this review, we focus on the biological and putative pathophysiological roles of CCN5. This intriguing protein is structurally unique among the CCN family members, and has a unique biological activity profile as well.

SUBMITTER: Russo JW

PROVIDER: S-EPMC2948116 | biostudies-other | 2010 Oct

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Genetics, Cell Biology, and Pathophysiology of Pancreatitis.

Project description: Not available

| S-EPMC6903413 | biostudies-literature

Emerging Roles of USP18: From Biology to Pathophysiology.

Project description: Not available

| S-EPMC7555095 | biostudies-literature

Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis.

Project description: Not available

| S-EPMC5887128 | biostudies-literature

CCN5, a novel transcriptional repressor

Project description:CCN5 is a member of the CCN (Connective Tissue Growth Factor/Cysteine-rich 61/Nephroblastoma overexpressed) family and was identified as an estrogen-inducible gene in estrogen receptor-positive cell lines. However, the role of CCN5 in breast carcinogenesis remains unclear. We report here that CCN5 protein is localized mostly in the cytoplasm, and in part in the nucleus, of human tumor breast tissue. Using a heterologous transcription assay, we demonstrate that CCN5 can act as a transcriptional repressor, presumably through association with histone deacetylase HDAC1. Microarray gene expression analysis showed that CCN5 represses expression of genes associated with epithelial-mesenchymal transition (EMT) as well as expression of key components of the TGF-beta signaling pathway, prominent among them TGF-betaRII receptor. We show that CCN5 is recruited to the TGF-betaRII promoter, thereby providing a mechanism by which CCN5 restricts transcription of the TGF-betaRII gene. Consistent with this finding, we found that CCN5 functions to suppress TGF-beta-induced transcriptional responses and invasion that is concomitant with EMT. Thus, our data uncovered CCN5 as a novel transcriptional repressor that plays an important role in regulating tumor progression functioning, at least in part, by inhibiting the expression of genes involved in the TGF-beta signaling cascade that is known to promote EMT.

2011-11-30 | GSE25431 | GEO

CCN5, a novel transcriptional repressor

2011-11-30 | E-GEOD-25431 | biostudies-arrayexpress

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Project description: Not available

| S-EPMC3209715 | biostudies-literature

CCN5, a novel transcriptional repressor

Project description: Not available

| S-ECPF-GEOD-25431 | biostudies-other

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology.

Project description: Not available

| S-EPMC3299091 | biostudies-literature